Skip to main content

News Archive

May 2, 2017 "Determining exactly who has or is at risk for the disease is a critical unmet medical need," said first authorRohit Loomba, MD, professor of..." "Stool Microbes Predict Advanced Liver Disease "

December 9, 2016 - Dr. Loomba's work on better ways to detect nonalcoholic fatty liver disease is featured in the UC San Diego Health Sciences News tumblr blog story, "Detecting Liver Disease: Two Imaging Methods Go Head to Head"

October 6, 2016 - Dr. Loomba is a quoted expertin the STAT story, "As a stealthy liver disease becomes more common, the search for treatments accelerates"

October3, 2016 - Dr. Loomba and his work are featured in "A silent liver disease epidemic," the cover story in the October 3 issue of Chemical and Engineering News

July 28, 2016, World Hepatitis Day- Dr. Loomba interviewed with Scott A. Suckow of the American Liver Foundation on KUSINews

July 5, 2016 - Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis" - Dr. Loomba is senior author on the report published online in Therapeutic Advances in Gastroenterology | Read the Abstract

June 16, 2016 - Published in Hepatology - NAFLD Research Center findings suggest shared genetic effects between hepatic steatosis and fibrosis | Read accepted article

May 16, 2016 - Dr. Loomba presents UC San Diego Progress in the Science of Medicine (PRISM) Lecture, "Innovative Study Design and Novel Imaging in Nonalcoholic Steatohepatitis," 12 - 1 p.m., Garren Auditorium, Biomedical Sciences Building | View event flyer

May 12, 2016 - Diabetes Drug Found No Better Than Placebo at Treating NAFLD - But randomized, double-blind clinical trial suggests better way to conduct future trials - Dr. Loomba is senior author on the report in the Journal of Hepatology

April 5, 2016 - UC San Diego NAFLD Research Center Finds Novel 3D Imaging Tool Provides Accurate, Less Invasive Method for Diagnosing Advanced Fibrosis in Liver - Dr. Loomba is first author on the report in The American Journal of Gastroenterology | Reported in Science Daily

February 2016 - UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center Directed by Dr. Loomba | Reported in the San Diego Union-Tribune

October 23, 2015 - Dr. Loomba listed as GI Physician Leader to Know in Becker's GI & Endoscopy

October 1, 2015 - Dr. Loomba and Coworkers Find Fatty Liver Disease and Scarring Have Strong Genetic Component

May 2015 - Dr. Loomba and UC San Diego colleague Claude B. Sirlin, MD , receive five-year R01 research grant from NIDDK to fund their study, "Quantitative Ultrasound (QUS) Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD."

March 2, 2015 - Dr. Loomba is quoted in the Washington Post article, "Heavy drinking is not the only cause of serious liver trouble."

Fall 2012 - Dr. Rohit Loomba was interviewed by Howard Hughes Medical Institute (HHMI) about non-alcoholic fatty liver disease. HHMI, a non-profit research organization plays a prominent role in advancing biomedical research and organization. | Complete link to the article: HHMI Bulletin - Fatty Liver | About HHMI:

March 15, 2012 - Dr. Rohit Loomba was honoredby Combined Health Agencies at their 18 th annual Health Hero Awards breakfast in Balboa Park on March 15, 2012. The American Liver Foundation considers Dr. Rohit Loomba an enthusiastic, collaborative partner as he serves on the National Board of Directors and the non-profit local Speakers Bureau promoting prevention and care. Combined Health Agencies is a federation of 24 local health charities which has been United Way's health partner in the United Way/CHAD Campaign since 1974.

December 6, 2011 - Dr. Loomba Elected to the National Board of Directors of the American Liver Foundation.

Dear Dr. Loomba,

As Chair of the American Liver Foundation (ALF) Board of Directors (BOD), it is my special privilege to tell you that you were elected as a member of the 2012 Board of Directors during last Saturday’s Annual Meeting of the Delegate Assembly. I want to thank you for your willingness and commitment to serve on our Board. You will bring a special expertise and a unique perspective to the challenges and opportunities ahead.

These are very exciting times for the American Liver Foundation as we work together to advance our mission to facilitate, advocate, and promote education, support, and research for the prevention, treatment and cure of liver disease. In order to ensure our success, we continue to engage the best and brightest volunteer and staff leadership available. We are delighted to have you join our team.

To ensure that you have a full understanding of our organization as well as the specific responsibilities for individual Board and Committee members, we are in the process of planning an orientation program for all newly elected Board members. This Board Orientation will be conducted in early January via conference call/webinar. More details will be available soon.

Donna Cryer
Chair, American Liver Foundation Board of Directors